Taiwan Healthcare+ Portal
2021台灣醫療科技展 Logo 與 Banner 下載
亞洲醫療科技創新論壇 MEDTEX Summit Asia
跨域領袖對話峰會 - AI 醫療的契機與挑戰
大健康產業國際競爭力論壇 - 遠距醫療、精準醫療、細胞治療
Vaccine developer Adimmune sets up first overseas manufacturing site in Indonesia
The new plant will be situated in the Special Economic Zone in East Java JIIPE, Indonesia, focusing on biologics.
Medical device developer MiiS’ AI-DR granted Class II clearance by TFDA
AI-DR is the world's first AI-powered software that identifies DR by types, stages and lesions- all at the same time.
TCI Bio inks manufacturing deal with US company
TCI acquires a manufacturing facility from US-based NewAge and strikes a long-term deal with the company for manufacturing and global expansion
Acer makes headway in SEA markets with VeriSee DR (Diabetic Retinopathy) medical software
VeriSee has been approved by Thailand and Indonesia's FDA, with aims at market expansion in Asia
PharmaEssentia on BBC, treatment for rare disease
P1101, a new drug developed by PharmaEssentia, which targets the rare disease myeloproliferative neoplasms (MPNs), is now featuring on BBC StoryWorks
Taiwan authorizes domestic production of at-home COVID test kits
A domestic production of one type of rapid coronavirus test kits for use at home has been approved by Taiwan FDA
Amazon selling its own COVID-19 test kits for $39.99
The nasal swab test provides results within 24 hours after samples arrive at Amazon's labs
Home-based COVID testing kits to arrive in Taiwan next week
Those who test positive asked to get second test at designated screening center
Taiwan-developed drug to be tested on severe COVID-19 cases in U.S.
A drug candidate developed by Golden Biotechnology Corp. of COVID-19 will be administered to seriously ill patients in its Phase II clinical trials in the United States, awaiting authorisation by the relevant authorities.
Virtual medical services available for chronically ill
The service provides remote care via video conferencing or telephone, targets outpatients with chronic diseases or people in need of outpatient services. (Photo courtesy of Taipei Medical University Hospital)
Oxford University and Oracle partner to speed identification of COVID-19 variants
The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.
Expo Announcement: Exhibitor booth selection rescheduled
Booth selection rescheduled on 15 June for exhibitors with 6+ booths and 30 July for others.
Amgen’s Lumakras secures FDA nod for NSCLC with KRAS G12C mutation
Guardant Health liquid biopsy test and Qiagen’s tissue-based test receive FDA approval as CDx for Lumakras. Photo credit: Ajale from Pixabay)
Acepodia Presents Data on its Allogeneic Natural Killer-Like Gamma-Delta T Cell Therapy, ACE1831, in Development for Hematological Cancers
Taiwan approves AI-based detection system for COVID-19
The system will help doctors to read chest X-rays and thus more quickly detect COVID-19 infections.
Google Strikes Deal With Hospital Chain to Develop Healthcare Algorithms
Tech giant expands health-sector presence in latest deal to develop tools to improve medical care, as privacy concerns arise.
Foresee Pharmaceuticals gains FDA approval of prostate cancer drug
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization
TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India
The approval aids in the country’s emergency of acute liposomal amphotericin B shortage.
Taiwan-based vaccine maker to form joint venture with Singapore firm
Adimmune Corp. will be introducing vaccines for influenza, tetanus and enterovirus into Southeast Asian markets in the initial stage, once the joint venture has been established.
Covid-19: Three strategies for alleviating healthcare workloads and public panic
Strategies by IBMI to address issues flagged by healthcare providers and around panic of getting infected.
© 社團法人國家生技醫療產業策進會 & 財團法人生技醫療科技政策研究中心 版權所有